Torcida GME, Hernández HRJ, Ochoa TM, Ramírez SLF

Language: Spanish
References: 10
Page: 238-243
PDF size: 441.03 Kb.

ABSTRACT

Polycystic kidney disease is a common genetic cause of chronic kidney disease, characterized by the formation of multiple cysts in the kidneys and other organs, occurs in 1 in 20,000 live births. 30 to 50% of affected newborns die shortly after birth because of respiratory and renal insufficiency. This study reports the case of a newborn with polycystic kidney disease diagnosed by obstetric ultrasound at 26 weeks of gestation and kidneys anhidramnios due to increased volume and appearance “in sponge.” Neonato a primigravida 19 years of age. At 26 weeks you will be detected in a routine obstetric evaluation that measures were in line for somatométricas fetal gestational age, and anhidramnios increase in renal mass and bilateral thorax narrow. The pregnancy ended in a cesarean section at 37 weeks with a newborn of 3140 g, women who died within minutes after birth. We requested an autopsy because of the need for genetic counseling. The findings were: enlarged kidneys with microcystic dilatation of collecting duct and in the renal cortex and medulla, liver fibrosis and Müllerian duplication with double uterine cavity. It is a rare association between polycystic kidney disease and Müllerian duplication, liver fibrosis confirmed by autopsy and has not been documented previously.

REFERENCES

1. Guay-Wooford L, Desmond R. Autosomal recessive polycystic kidney disease: The clinical experience in North America. Pediatrics 2003;111:1072-80.

2. Lespinasse J, Fourcade J, Schir F. Polycystic kidney diseases: molecular genetics and counselling. Nephrol Ther 2006;2:120-6.

3. Sessa A, Righetti M, Battini G. Autosomal recessive and dominant polycystic kidney diseases. Minerva Urol Nefrol 2004;56:329-38.

4. Eichenwald S. Current Therapy Pediatrics 1989. Tomo II: 891-892. Ed. BC. Decker.

5. Igarashi P, Solmo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002;13:2384-98.

6. Carsten B, Senderek J, Sedlacek B, Pegiazoglou I, et al. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 2003;13:76-89.

7. Martinez JR, Grantham JJ. Polycystic kidney disease: etiology, pathogenesis and treatment. Dis Mon 1995;41:693-765.

8. Adeva M, El-Youssef M, Rossetti S, Kamath PS, et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine 2006;85:1-21.

9. Bergmann C, Senderek J, Windelen E, Kupper F, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal recessive polycystic kidney disease. Kidney Int 2005;67:829-48.

10. Harris P, Fodor D, Cavagnaro F, Di Egidio M, et al. Congenital hepatic fibrosis. Report of five cases. Rev Med Chil 2004;132:733-41.